| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/30/1996 | US5487984 Processes for producing tumor necrosis factor |
| 01/30/1996 | US5487983 Expression systems for making single-chain monellin analogs |
| 01/30/1996 | US5487982 Method of obtaining immunogenic peptides from cells expressing temperature-sensitive mutants of major histocompatibility complex molecules |
| 01/30/1996 | US5487980 Improved method for producing polypeptides by bacterial fermentation |
| 01/30/1996 | US5487979 DNA encoding human and murine eps15, a substrate for the epidermal growth factor receptor |
| 01/30/1996 | US5487976 Genetic engineering |
| 01/30/1996 | US5487974 Contact blood samples and determine proliferation of cytolytic lymphocytes and lysis of cells presenting said complexes |
| 01/30/1996 | US5487970 Compositions and methods for detecting gene rearrangements and translocations |
| 01/30/1996 | US5487889 Envelope encloses cells that secrete wound healing growth factors; genetic engineering |
| 01/30/1996 | CA1338011C Oncostatin m and novel compositions having anti-neoplastic activity |
| 01/30/1996 | CA1338010C Heat shock promoter and gene |
| 01/28/1996 | CA2154640A1 Coated pesticidal agents, processes for their preparation and compositions containing them |
| 01/26/1996 | CA2154129A1 Endothelin-antagonizing peptide |
| 01/25/1996 | WO1996002004A1 Immunoassay for mycophenolic acid |
| 01/25/1996 | WO1996002000A1 E6 binding proteins |
| 01/25/1996 | WO1996001907A1 NOVEL p53 RESPONSE GENES |
| 01/25/1996 | WO1996001903A1 Fusion proteins comprising gm-csf and antigens and their expression in yeast |
| 01/25/1996 | WO1996001900A1 Immunodominant polypeptides |
| 01/25/1996 | WO1996001899A1 METHOD FOR IDENTIFYING NUCLEIC ACIDS ENCODING c-fos PROMOTER ACTIVATING PROTEINS |
| 01/25/1996 | WO1996001898A1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/25/1996 | WO1996001897A1 Blue light photoreceptors and methods of using the same |
| 01/25/1996 | WO1996001896A1 Connective tissue growth factor-2 |
| 01/25/1996 | WO1996001891A1 Method for generating a population of cells having a high surface density of a mhc molecule-associated specific exogenous peptide, and cell population |
| 01/25/1996 | WO1996001846A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
| 01/25/1996 | WO1996001844A1 Proteins associated with tumor necrosis factor receptor |
| 01/25/1996 | WO1996001843A1 Polypeptide produced by stromal cell |
| 01/25/1996 | WO1996001842A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 01/25/1996 | WO1996001839A1 Novel cytokine designated lerk-5 |
| 01/25/1996 | WO1996001837A1 Compositions and methods of making and using human full length trk-b |
| 01/25/1996 | WO1996001653A1 Methods and compositions for the specific coagulation of vasculature |
| 01/25/1996 | WO1996001650A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | WO1996001644A1 Inhibitors of leukocyte adhesion |
| 01/25/1996 | WO1996001643A1 IgE ANTAGONISTS |
| 01/25/1996 | WO1996001642A1 Tumor necrosis factor receptor-ii-associated protein kinase and methods for its use |
| 01/25/1996 | WO1996001636A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | WO1996001615A2 Hepatitis a virus deletion mutants and vaccine formulations containing the same |
| 01/25/1996 | WO1996001557A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/25/1996 | WO1995032292A3 Detection of viral antigens coded by reverse-reading frames |
| 01/25/1996 | WO1995032221A3 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 01/25/1996 | DE4425527A1 Nucleic acid encoding signal peptide of Bacillus stearothermophilus S-layer protein |
| 01/25/1996 | CA2194768A1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/25/1996 | CA2194765A1 Connective tissue growth factor-2 |
| 01/25/1996 | CA2194591A1 Blue light photoreceptors and methods of using the same |
| 01/25/1996 | CA2194566A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | CA2194548A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/25/1996 | CA2194451A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 01/25/1996 | CA2194439A1 Immunoassay for mycophenolic acid |
| 01/25/1996 | CA2194366A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | CA2194361A1 Method for identifying nucleic acids encoding c-fos promoter activating proteins |
| 01/25/1996 | CA2194299A1 Novel cytokine designated lerk-5 |
| 01/25/1996 | CA2193508A1 Inhibitors of leukocyte adhesion |
| 01/24/1996 | EP0693687A1 Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
| 01/24/1996 | EP0693555A1 Potyvirus coat protein genes and plants transformed therewith |
| 01/24/1996 | EP0693554A1 Crucifer aft proteins and uses thereof |
| 01/24/1996 | EP0693523A2 Collagen-based matrix |
| 01/24/1996 | EP0693286A1 Pharmaceutical composition comprising furin |
| 01/24/1996 | EP0693129A1 Method of inhibiting the transcription of genes |
| 01/24/1996 | EP0693126A1 Method for selective inactivation of viral replication |
| 01/24/1996 | EP0693125A1 Fusion proteins between antigenic amino acid sequences and beta-2-microglobulin |
| 01/24/1996 | EP0693124A1 Human osteoclast-specific and -related genes |
| 01/24/1996 | EP0693122A1 Glutamylcysteine synthetase light subunit |
| 01/24/1996 | EP0693085A1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof |
| 01/24/1996 | EP0693084A1 Chimeric cytokine receptors in lymphocytes |
| 01/24/1996 | EP0693083A1 Alpha-ketoamide derivatives as inhibitors of thrombosis |
| 01/24/1996 | EP0692982A1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
| 01/24/1996 | EP0692981A1 Chelators of type xn 1?s 1?x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses |
| 01/24/1996 | EP0692980A1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use |
| 01/24/1996 | EP0692979A1 Bifunctional chelators and their use in radiopharmaceuticals |
| 01/24/1996 | EP0692976A1 Chelating agents of the type xn 1?s 1?o 1? for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy |
| 01/24/1996 | EP0692973A1 Peptide coated dendritic cells as immunogens |
| 01/24/1996 | EP0692971A1 Analogs of peptide yy and uses thereof |
| 01/24/1996 | EP0692970A1 Method for reducing the viscosity of pathological mucoid airway contents in the respiratoy tract |
| 01/24/1996 | EP0692968A1 Urokinase plasminogen activator fragments |
| 01/24/1996 | EP0692967A1 Method of inhibiting radiation induced weight and hair loss |
| 01/24/1996 | EP0692930A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 01/24/1996 | EP0631617A4 Colon crypt cell mitogen, cell line producing it, and uses thereof. |
| 01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
| 01/24/1996 | EP0440619B1 Antibody to a4 amyloid peptide |
| 01/24/1996 | CN1115252A Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides |
| 01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 01/23/1996 | US5486602 Genes encoding serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors |
| 01/23/1996 | US5486599 Construction and use of synthetic constructs encoding syndecan |
| 01/23/1996 | US5486597 Gastrin antagonist as antisecretory agents of gastric juice for stomach cancer |
| 01/23/1996 | US5486595 Tumor necrosis factor inhibitors |
| 01/23/1996 | US5486505 Polypeptide compounds having growth hormone releasing activity |
| 01/23/1996 | US5486503 Anti-fungal histatin-based peptides |
| 01/23/1996 | US5486476 Lipoprotein (a) peptides and their use |
| 01/23/1996 | US5486473 Genetic engineering |
| 01/23/1996 | US5486472 Polypeptides |
| 01/23/1996 | US5486465 Teicoplanin recovery process |
| 01/23/1996 | US5486463 TNF-muteins |
| 01/23/1996 | US5486462 Differentiative expression modules |
| 01/23/1996 | US5486456 Method of diagnosing ovarian, endometrial, and colon cancers with monoclonal antibodies OXA and OXB |
| 01/23/1996 | US5486453 Antibodies to human papillomavirus latent proteins, diagnostic systems and methods |
| 01/23/1996 | CA2154379A1 Parietaria allergens |
| 01/23/1996 | CA1337976C Insulin precursors |
| 01/18/1996 | WO1996001430A2 Screening for nuc inhibitors |